Industry News
Pharmaceutical Industry News
Biogen’s Aduhelm probe in Congress escalates as lawmakers ask for info on FDA meetings, pricing tactics
Biogen's Aduhelm probe in Congress escalates as lawmakers ask for info on FDA meetings, pricing tactics nhigginsdunn Tue, 07/13/2021 - 11:24
AstraZeneca, FibroGen’s roxadustat hit with tough safety questions in FDA review ahead of key expert meeting
AstraZeneca, FibroGen's roxadustat hit with tough safety questions in FDA review ahead of key expert meeting aliu Tue, 07/13/2021 - 11:16
Sanofi inks national Olympic sponsorship for Paris 2024, reinforces social and environmental goals
Sanofi inks national Olympic sponsorship for Paris 2024, reinforces social and environmental goals bbulik Tue, 07/13/2021 - 10:11
Sanofi joins the Paris 2024 team, inking a $94M-plus national Olympic sponsorship
Sanofi joins the Paris 2024 team, inking a $94M-plus national Olympic sponsorship bbulik Tue, 07/13/2021 - 10:11
Ena starts phase 1 trial of COVID-19-preventing nasal spray
Ena starts phase 1 trial of COVID-19-preventing nasal spray ntaylor Tue, 07/13/2021 - 10:08
Curia, on heels of rebrand, snaps up CDMO Integrity Bio to expand westward
Curia, on heels of rebrand, snaps up CDMO Integrity Bio to expand westward fkansteiner Tue, 07/13/2021 - 09:34
Fresenius launches ready-to-administer prefilled fentanyl syringe
Fresenius launches ready-to-administer prefilled fentanyl syringe ntaylor Tue, 07/13/2021 - 08:38
Opiant’s nasal opioid overdose drug clears clinical test ahead of planned FDA filing
Opiant's nasal opioid overdose drug clears clinical test ahead of planned FDA filing ntaylor Tue, 07/13/2021 - 08:31
U.K. makes novel vaccine delivery a focus of life science plans
U.K. makes novel vaccine delivery a focus of life science plans ntaylor Tue, 07/13/2021 - 08:26
U.S. Officials Press Pfizer for More Evidence of Need for Booster Shot
After meeting with company representatives, officials said the decision would depend partly on data on infections in vaccinated people that cause serious disease or hospitalization.
F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccine
Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.
With the Delta Variant, Do I Need a Covid Booster Shot?
Although studies of a third dose are underway, experts agree that the vaccines are still working well, even against the Delta variant, and that booster shots are not necessary right now.
Guardant nabs chief commercial officer from Gilead as it preps more ‘liquid biopsy’ rollouts
Guardant nabs chief commercial officer from Gilead as it preps more 'liquid biopsy' rollouts bbulik Mon, 07/12/2021 - 20:13
Gilead’s Veklury shows ‘no antiviral effects’ against COVID-19 in small WHO study
Gilead's Veklury shows 'no antiviral effects' against COVID-19 in small WHO study nhigginsdunn Mon, 07/12/2021 - 14:59
Gilead’s Veklury shows ‘no antiviral effects,’ small WHO study says as company stands by COVID med
Gilead's Veklury shows 'no antiviral effects,' small WHO study says as company stands by COVID med nhigginsdunn Mon, 07/12/2021 - 14:59
Johnson & Johnson’s COVID-19 shot hit again as feds plan to tag Guillain-Barré warning on label: reports
Johnson & Johnson's COVID-19 shot hit again as feds plan to tag Guillain-Barré warning on label: reports esagonowsky Mon, 07/12/2021 - 14:30
With Takhzyro durability data, Takeda tries to fend off BioCryst’s hereditary angioedema challenger Orladeyo
With Takhzyro durability data, Takeda tries to fend off BioCryst's hereditary angioedema challenger Orladeyo kdunleavy Mon, 07/12/2021 - 13:06
China’s Sinovac, Sinopharm ink COVAX supply deal for up to 550M coronavirus vaccine doses
China's Sinovac, Sinopharm ink COVAX supply deal for up to 550M coronavirus vaccine doses nhigginsdunn Mon, 07/12/2021 - 11:21
Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analyst
Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analyst aliu Mon, 07/12/2021 - 10:29
With sweeping executive order, Biden puts drug pricing, anti-competitive strategies in the crosshairs
With sweeping executive order, Biden puts drug pricing, anti-competitive strategies in the crosshairs fkansteiner Mon, 07/12/2021 - 09:51